Breaking News

How NYU Langone is addressing organ shortage for transplants

Not rendering correctly? View this email as a web page here.

Cancer care poses challenges for employers; Transcarent shares vision for how it can help [Sponsored]

By Stephanie Baum Wednesday, July 13, 2022 7:30 AM

As they seek to support their staff, self-insured employers are turning to innovative programs to balance evidence based programs with the need to manage healthcare costs.

Read more »

Moving Analytics raises $20M to scale customer base for cardiac telehealth program

By Katie Adams Tuesday, July 12, 2022 6:46 PM

Moving Analytics, a telehealth startup that provides remote cardiac rehab, raised $20 million in Series A funding. It will use the funds to scale its platform, expand its presence in the market and develop content focusing on heart health among women and people of color.

Read more »

Why stigma continues to exacerbate the United States' drug epidemic

By Dr. Nishi Rawat Tuesday, July 12, 2022 6:12 PM

Since we know the fundamental causes of the opioid epidemic, why are we still here? It all centers around stigma.

Read more »

Neuro startups form latest group of grads from PharmStars digital health accelerator

By Frank Vinluan Tuesday, July 12, 2022 5:53 PM

PharmStars, a digital health accelerator, graduated its latest cohort of startups, each of them developing a solution addressing some aspect of neurological disease. The accelerator is accepting applications for the next group of startups for the fall program. The theme is innovations in real-world evidence.

Read more »

Yuvo Health, Centene subsidiary hope to bring value-based care to FQHCs in New York

By Marissa Plescia Tuesday, July 12, 2022 5:40 PM

A new partnership between Yuvo Health, an administrative and managed-care solution for community health centers, and Centene subsidiary Fidelis Care aims to bring value-based care to federally qualified health centers in New York and its Medicaid population.

Read more »

Areteia gets $350M to turn failed ALS drug into a therapy for severe asthma

By Frank Vinluan Tuesday, July 12, 2022 2:39 PM

New company Areteia Therapeutics launched with up to $350 million in financing and an asthma drug candidate from Knopp Biosciences. That drug, dexpramipexole, previously failed a pivotal test in amyotrophic lateral sclerosis but more recent clinical testing found that the way the small molecule works has applications in eosinophilic asthma, a severe form of the respiratory disease.

Read more »

   

No comments